Bridgebio Pharma, Inc. · NASDAQ:BBIO
Valantine Hannah sold 5,004 Bridgebio Pharma, Inc. shares (Form 4)
Traded Jun 22 to Jun 23, 2026 · Filed Jun 24, 2026
From Jun 22 to Jun 23, 2026, Valantine Hannah (Director) sold 5,004 Bridgebio Pharma, Inc. shares at an average US$68.25 for US$342K under a trading plan, leaving 9,259 shares. Filed Jun 24, 2026 (Form 4).
- Sold
- 5,004 shares
- Price
- US$68.25 average (US$68.00 to US$68.57)
- Value
- US$342K
- Holding after
- 9,259 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | Award | 3,990 | 11,455 | Direct | |
| Jun 22, 2026 | Common Stock | Option exercise | 2,808 | US$41.73 | 14,263 | Direct |
| Jun 22, 2026 | Common Stock | Sale | 2,808 | US$68.00 | 11,455 | Direct |
| Jun 23, 2026 | Common Stock | Sale | 2,196 | US$68.57 | 9,259 | Direct |